http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2098521-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90f4ee566d9768b969cde8b1de75ad0d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
filingDate 2008-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3965f6b979de7d84012214c75b0cede
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0044bfa2bb537c3c9994161851015f54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85400f70d7ed0fd9e2ebd5ed28140f2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_425b6ed709e3d14d722d168c865cdd9e
publicationDate 2009-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2098521-A1
titleOfInvention Crystal forms of N-[2-(diethylamino) ethyl]-5-[fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrolle-3-carboxamide and methods for their prepparation
abstract The present invention relates to novel crystal forms of Sunitinib and methods for their preparation. Sunitinib has the following chemical structure:
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010023473-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010023473-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2220072-A2
priorityDate 2008-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03035009-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1255536-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1255752-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1255752-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03070725-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0160814-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6456016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3086686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425795698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247499656

Total number of triples: 42.